Cns Pharmaceuticals Stock Market Value
| CNSP Stock | USD 0.12 0.01 7.69% |
| Symbol | Cns |
Cns Pharmaceuticals Price To Book Ratio
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cns Pharmaceuticals. If investors know Cns will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cns Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (352.97) | Return On Assets (2.24) | Return On Equity (10.19) |
The market value of Cns Pharmaceuticals is measured differently than its book value, which is the value of Cns that is recorded on the company's balance sheet. Investors also form their own opinion of Cns Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Cns Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cns Pharmaceuticals' market value can be influenced by many factors that don't directly affect Cns Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cns Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cns Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cns Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cns Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Cns Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Cns Pharmaceuticals.
| 10/26/2024 |
| 11/25/2024 |
If you would invest 0.00 in Cns Pharmaceuticals on October 26, 2024 and sell it all today you would earn a total of 0.00 from holding Cns Pharmaceuticals or generate 0.0% return on investment in Cns Pharmaceuticals over 30 days. Cns Pharmaceuticals is related to or competes with Capricor Therapeutics, Soleno Therapeutics, Bio Path, Moleculin Biotech, Crinetics Pharmaceuticals, Assembly Biosciences, and Instil Bio. CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, engages in the development of anti-cancer drug candidates ... More
Cns Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Cns Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Cns Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.05) | |||
| Maximum Drawdown | 39.29 | |||
| Value At Risk | (11.76) | |||
| Potential Upside | 9.09 |
Cns Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Cns Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Cns Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Cns Pharmaceuticals historical prices to predict the future Cns Pharmaceuticals' volatility.| Risk Adjusted Performance | (0.02) | |||
| Jensen Alpha | (0.47) | |||
| Total Risk Alpha | (1.44) | |||
| Treynor Ratio | (0.17) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Cns Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Cns Pharmaceuticals Backtested Returns
Cns Pharmaceuticals secures Sharpe Ratio (or Efficiency) of -0.0436, which signifies that the company had a -0.0436% return per unit of risk over the last 3 months. Cns Pharmaceuticals exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Cns Pharmaceuticals' Mean Deviation of 4.99, standard deviation of 7.38, and Risk Adjusted Performance of (0.02) to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 1.59, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Cns Pharmaceuticals will likely underperform. At this point, Cns Pharmaceuticals has a negative expected return of -0.31%. Please make sure to confirm Cns Pharmaceuticals' total risk alpha, kurtosis, as well as the relationship between the Kurtosis and day typical price , to decide if Cns Pharmaceuticals performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.41 |
Average predictability
Cns Pharmaceuticals has average predictability. Overlapping area represents the amount of predictability between Cns Pharmaceuticals time series from 26th of October 2024 to 10th of November 2024 and 10th of November 2024 to 25th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Cns Pharmaceuticals price movement. The serial correlation of 0.41 indicates that just about 41.0% of current Cns Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.41 | |
| Spearman Rank Test | -0.46 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Cns Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Cns Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Cns Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Cns Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Cns Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Cns Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Cns Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Cns Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Cns Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Cns Pharmaceuticals Lagged Returns
When evaluating Cns Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Cns Pharmaceuticals stock have on its future price. Cns Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Cns Pharmaceuticals autocorrelation shows the relationship between Cns Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Cns Pharmaceuticals.
Regressed Prices |
| Timeline |
Pair Trading with Cns Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cns Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cns Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving together with Cns Stock
Moving against Cns Stock
| 0.72 | BMY | Bristol Myers Squibb Sell-off Trend | PairCorr |
| 0.7 | GILD | Gilead Sciences | PairCorr |
| 0.68 | EWTX | Edgewise Therapeutics | PairCorr |
| 0.6 | KZR | Kezar Life Sciences | PairCorr |
| 0.59 | VRDN | Viridian Therapeutics | PairCorr |
The ability to find closely correlated positions to Cns Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cns Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cns Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cns Pharmaceuticals to buy it.
The correlation of Cns Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cns Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cns Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cns Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Cns Stock Analysis
When running Cns Pharmaceuticals' price analysis, check to measure Cns Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cns Pharmaceuticals is operating at the current time. Most of Cns Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Cns Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cns Pharmaceuticals' price. Additionally, you may evaluate how the addition of Cns Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.